International Association for the Study of Lung Cancer (IASLC) shared a post on LinkedIn:
“If you’re attending the IASLC Asia Conference on Lung Cancer (ACLC 2025), you may want to attend the following sponsored symposium MSD.
IS01: A Decade of Progress – The Evolution of Immunotherapy in Non-Small Cell Lung Cancer
Friday, 10 October | 12:15–13:15 (GMT+7)
Saigon 2, Ho Chi Minh City
The session will review how innovative therapies, particularly immunotherapy, have transformed lung cancer treatment, with discussion on progress, challenges, and emerging opportunities across the Asia-Pacific region.”
More posts featuring IASLC on OncoDaily.